Skip to main content
Terug
Watch Compare

CollPlant Biotechnologies Ltd

Datakwaliteit: 100%
CLGN
Nasdaq Manufacturing Measuring & Analyzing Instruments
€ 0,38
▼ € 0,00 (-0,52%)
Marktkapitalisatie: 5,34 M
Prijs
€ 0,37
Marktkapitalisatie
5,34 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Revenue declined -37,60% annually over 5 years
Negative free cash flow of -9,45 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 397,99%
Capital efficient — spends only 1,18% of revenue on capex

Groei

Revenue Growth (5Y)
-37,60%
Onder sectorgemiddelde (1,82%)
Revenue (1Y)360,39%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-40,48%
Boven sectorgemiddelde (-53,47%)
ROIC-29,21%
Net Margin-484,56%
Op. Margin-484,31%

Veiligheid

Debt / Equity
N/A
Current Ratio6,27
Interest CoverageN/A

Waardering

PE (TTM)
-0,46
Boven sectorgemiddelde (-1,48)
P/B Ratio0,26
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -0,5 -1,5
P/B 0,3 1,6
ROE % -40,5 -53,5
Net Margin % -484,6 -41,5
Rev Growth 5Y % -37,6 1,8
D/E — 0,3

Koersdoel Analisten

1 analist
Geen analistendekking beschikbaar

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 -€ 0,18
-€ 0,18 – -€ 0,18
 7,86 M 1
FY2026 -€ 0,59
-€ 0,59 – -€ 0,59
 6,29 M 1

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q42025 -€ 0,19 -€ 0,25 -31,6%
Q32025 € 0,16 -€ 0,27 -274,2%
Q22025 -€ 0,10 -€ 0,28 -180,0%
Q12025 -€ 0,04 -€ 0,13 -225,0%

All Fundamental Metrics
Growth
Revenue Growth (1Y) 360,39% Revenue Growth (3Y) -53,49%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -37,60% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 2,37 M Net Income (TTM) -11,49 M
ROE -40,48% ROA -33,72%
Gross Margin 64,78% Operating Margin -484,31%
Net Margin -484,56% Free Cash Flow (TTM) -9,45 M
ROIC -29,21% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 6,27
Interest Coverage N/A Asset Turnover 0,07
Working Capital 17,09 M Tangible Book Value 20,57 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,46 Forward P/E N/A
P/B Ratio 0,26 P/S Ratio 2,25
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -177,07%
Market Cap 5,34 M Enterprise Value -13,58 M
Per Share
EPS (Diluted TTM) -0,94 Revenue / Share 0,16
FCF / Share -0,66 OCF / Share -0,65
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 1,18% FCF Conversion 82,23%
SBC-Adj. FCF N/A Growth Momentum 397,99

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 2,37 M 515.000,0 10,96 M 299.000,0 15,64 M
Net Income -11,49 M -16,61 M -7,02 M -16,93 M 237.000,0
EPS (Diluted) -0,94 -1,45 -0,62 -1,53 0,02
Gross Profit 1,54 M -1,11 M 8,97 M -101.000,0 13,64 M
Operating Income -11,48 M -17,25 M -7,51 M -17,10 M 65.000,0
EBITDA — — — — —
R&D Expenses 8,19 M 10,52 M 10,48 M 10,26 M 7,63 M
SG&A Expenses — — — — —
D&A 912.000,0 1,04 M 1,10 M — —
Interest Expense — — — — —
Income Tax — 45,99 M 59,99 M — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 10,79 M 18,71 M 34,13 M 37,77 M 51,22 M
Total Liabilities 4,70 M 5,25 M 5,79 M 5,49 M 6,10 M
Shareholders' Equity 6,08 M 13,47 M 28,34 M 32,28 M 45,12 M
Total Debt — — — 321.000,0 249.000,0
Cash & Equivalents 5,59 M 11,91 M 26,67 M 29,65 M 13,15 M
Current Assets 6,75 M 13,18 M 28,02 M 31,66 M 45,09 M
Current Liabilities 2,67 M 2,97 M 3,25 M 3,11 M 3,01 M